Pharmacologic implications of alterations in the metabolism of chloramphenicol.
D000081:Acetamides / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism; D001565:Benzoates / Q000378:metabolism; D002701:Chloramphenicol / Q000378:metabolism* / Q000494:pharmacology; D005215:Fasting; D005965:Glucuronates / Q000096:biosynthesis; D005966:Glucuronidase / Q000378:metabolism; D006591:Hexobarbital / Q000494:pharmacology; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D010627:Phenethylamines / Q000378:metabolism; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013056:Spectrophotometry, Ultraviolet; D013450:Sulfones / Q000378:metabolism; D013997:Time Factors; D014050:Toluene / Q000378:metabolism
D000081:Acetamides; D000900:Anti-Bacterial Agents; D001565:Benzoates; D005965:Glucuronates; D010627:Phenethylamines; D013450:Sulfones; D014050:Toluene; D002701:Chloramphenicol; D006591:Hexobarbital; D005966:Glucuronidase